Investor Inquiries
Where are Advicenne's corporate headquarters?
262, Rue du Faubourg Saint Honoré – 75008 Paris
When was the company founded?
Advicenne was founded in 2007 by Luc-André Granier and Caroline Roussel-Maupetit with the objective of developing and commercialising orphan drugs suitable for patients of all ages, and especially children, in the fields of neurology and nephrology.
When did Advicenne go public?
The Initial Public Offering took place in December 2017 on EURONEXT Paris. 27,8M€ has been raised.
On which markets is Advicenne listed?
Advicenne is today listed on Euronext Growth Paris (ALDVI – FR0013296746).
How is Advicenne’s stock traded?
Advicenne’s common stock is listed on Euronext Growth Paris under the symbol ALDVI.
What is Advicenne’s fiscal year?
Advicenne’s fiscal year ends December 31st.
How can I buy shares of the company? Who should I contact in order to do so?
You can contact your own bank or a good online broker.
How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
For all your questions related to your registered shares, you can contact BNPParibas, the bank that is in charge of Advicenne’s share register. They can be contacted by mail at the following address: paris.bp2s.cts.relations.actionnaires@corp.bnpparibas.com.
Does Advicenne have a direct stock purchase plan?
Advicenne does not have a stock purchase plan.
Who is Advicenne’s auditor?
The auditors of Advicenne are:
- KPMG, represented by Stéphane Devin, partner – 51, Rue Saint Cyr, 69338 LYON cedex
- Implid, represented by Alain Descoins, partner – 79 cours Vitton – CS 90047 – 69451 Lyon Cedex 06
Whom should I contact for investor inquiries?
Please send investor inquiries to investors@advicenne.com.